Reaktionsgleichung
[F:1][C@@H:2]1[CH2:6][N:5]([C:7]2[CH:12]=[CH:11][N:10]3[N:13]=[CH:14][C:15]([C:16]([O:18]CC)=[O:17])=[C:9]3[CH:8]=2)[C@@H:4]([C:21]2[CH:26]=[CH:25][CH:24]=[C:23]([F:27])[CH:22]=2)[CH2:3]1.[Li+].[OH-].[OH-].[Na+]>C1COCC1.CO.O>[F:1][C@@H:2]1[CH2:6][N:5]([C:7]2[CH:12]=[CH:11][N:10]3[N:13]=[CH:14][C:15]([C:16]([OH:18])=[O:17])=[C:9]3[CH:8]=2)[C@@H:4]([C:21]2[CH:26]=[CH:25][CH:24]=[C:23]([F:27])[CH:22]=2)[CH2:3]1Komponenten
Edukt 3
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Reaktionsbedingungen
- Temperatur
- 50 °C
Versuchsvorschrift
To a suspension of ethyl 5-((2R,4S)-4-fluoro-2-(3-fluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyridine-3-carboxylate (X-1) (51 mg, 0.14 mmol) in THF:MeOH:H2O 3:2:1 (3 mL) was added LiOH (29 mg, 0.7 mmol). The reaction was heated to 50° C. for 48 hours then cooled to room temperature and neutralized to pH 6 with 1M NaOH. The mixture was reduced to dryness and purified by column chromatography on silica gel with DCM/MeOH gradient as eluant to yield 5-((2R,4S)-4-fluoro-2-(3-fluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyridine-3-carboxylic acid (X-3). 1H NMR (400 MHz, CDCl3) δ 8.26 (s, 1 H), 8.15 (d, J=7.6 Hz, 1 H), 7.36-7.29 (m, 1 H), 7.09-7.04 (m, 2 H), 7.00-6.92 (m, 2 H), 6.24 (dd, J=2.4, 7.6 Hz, 1 H), 5.41 (d, J=52.8 Hz, 1 H), 5.06 (t, J=8.4 Hz, 1 H), 4.29-3.92 (m, 2 H), 2.94-2.82 (m, 1 H), 2.24-2.05 (m, 1 H). MS m/z 344.1 (M+1)+.
Aufarbeitung
- custompurified by column chromatography on silica gel with DCM/MeOH gradient as eluant
Quellen und Nachweise
- ORD-Eintrag
- ord-93e1cceba7e24f118c6db2a8632bc384
- Quelldatensatz
- uspto-grants-2015_08
- Patentnummer
- US09102671B2
Verknüpfte Notizen
Wird geladen…